1st half day 2nd half day dash 1st half month 2nd half month dash 1st digit year 2nd digit year 3rd digit year last digit year
Latest news on Acomplia
  • Acomplia Review Moved Forward - 26/03/2007
    Some good news for the makers of the new diet medication Acomplia namely Sanofi Aventis is that the Food & Drug Administration has ...
  • Acomplia Decision Confirmed In France - 23/03/2007
    Just over a month ago Ukmedix News reported that the French medical establishment had decided to recommend that the new weight loss drug ...
  • New Report On Acomplia's Potential Sales - 20/03/2007
    A new report that concerns the weight loss drug Acomplia has recently been released and it notes that it is likely to replace ...
  • Is Acomplia Any Different.... - 23/02/2007
    Sanofi Aventis are trying very hard to show that their weight loss drug Acomplia is completely different to the other weight loss drugs ...
  • France To Get Acomplia In March - 14/02/2007
    It looks like the French will see the weight loss drug Acomplia in pharmacies very soon following an announcement by the French drug ...
  • Good News For Acomplia - 07/02/2007
    At last some good news for Sanofi Aventis! The drug company has been facing delays in getting approval from the FDA in the ...
  • New Boss For Sanofi Aventis - 31/01/2007
    There is a new boss of the French drug giant Sanofi Aventis. Gérard Le Fur who will heading the company that makes the ...
  • Acomplia Ruling To Go To German Courts - 18/01/2007
    In a decision that was expected by all of us at Ukmedix the German Ministry of Health has decided that the Acomplia weight ...
  • Weight Loss Expert Explains Acomplia Mechanisms - 11/01/2007
    An expert on the weight loss drug Acomplia has recently been expounding his views on its effectiveness and has been explaining exactly how ...
  • Possible New Date For Acomplia In America - 20/12/2006
    Sanofi Aventis who are the makers of the weight loss drug Acomplia have given out information on a likely date for the approval ...
>> Click here to discuss Acomplia